Experimental blood pressure drug trial stopped early
NCT ID NCT06833190
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 29 times
Summary
This study tested an experimental drug called REGN5381 for people whose high blood pressure remains uncontrolled despite taking one or more medications. The goal was to see if the drug could lower blood pressure safely. The trial was terminated early after enrolling 34 participants. It was a phase 2b study sponsored by Regeneron Pharmaceuticals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNCONTROLLED HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Protas, Car Park of Asda Huyton Supercentre
Huyton, Liverpool, L36 7TX, United Kingdom
-
Protas, Car Park of Asda Pilsworth Road
Bury, BL9 8RS, United Kingdom
-
Protas, Two New Bailey Square
Salford, Manchester, M3 5GS, United Kingdom
Conditions
Explore the condition pages connected to this study.